F11R and neoplasm: In the current study we set out to address these knowledge gaps by characterizing the expression of JAM-A in circulating and tumor-infiltrating myeloid cells and by interrogating its role in myeloid cell recruitment and phenotypic diversification in tumors using mice with myeloid cell-specific JAM-A-deficiency.